Search - tctmd.com

Displaying 721 - 740 of 962

Sort: Relevancy | Date

News Industry News

Samsung Partnership with Scotland’s NHS Highlights Lifesaving Potential of Mobile Cardiac Diagnosis

July 28, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

July 25, 2013

News Daily News

Public Reporting of PCI Readmissions Unveiled, Though Results Questioned by Some

Caitlin E. Cox

July 25, 2013

News Daily News

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Caitlin E. Cox

July 11, 2013

News Daily News

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

Caitlin E. Cox

July 11, 2013

News Industry News

Cardiome Announces Commercialization Partnership For BRINAVESS™ In Select European Markets

July 03, 2013

News Industry News

Thoratec Acquires DuraHeart® II Ventricular Assist System

July 01, 2013

News Industry News

The AHA Exclusively Endorses Simulation Based Training from Medical Simulation Corporation and Raytheon Professional Services

June 25, 2013

Presentation TVT 2013

Updates from PARTNER 2A

Presenter: Martin Leon

June 13, 2013

Presentation TVT 2013

Can We Afford TAVR? Impact on US Hospitals and Health Systems: Lessons from PARTNER and Beyond

Presenter: David Cohen

June 13, 2013

Presentation TVT 2013

Did STS Score or EuroScore Risk Profiles Predict Mortality Outcomes in PARTNER?

Presenter: Brian Whisenant

June 12, 2013

Presentation TVT 2013

Vascular Complications: PARTNER Outcomes and Review of the Literature

Presenter: Philippe Généreux

June 12, 2013

Presentation TVT 2013

Stroke Frequency and Timing after TAVR: Evolving Insights from the PARTNER Database

Presenter: Samir Kapadia

June 12, 2013

Presentation TVT 2013

Retrospective Analysis of Poor Outcome Groups from the PARTNER Trial

Presenter: Nirat Beohar

June 12, 2013

News Daily News

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Yael L. Maxwell

May 31, 2013

News Daily News

Meta-análisis: Aumenta la prevalencia de la enfermedad y el número de candidatos a TAVR

Yael L. Maxwell

May 31, 2013

News Daily News

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

May 24, 2013

News Daily News

Registro: Mortalidad al Año Similar para la TAVR y la Cirugía en Pacientes de Riesgo Intermedio

May 24, 2013

News Conference News EuroPCR 2013

Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices

Jason Kahn

May 22, 2013

Advertisement

Samsung Partnership with Scotland’s NHS Highlights Lifesaving Potential of Mobile Cardiac Diagnosis

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

Public Reporting of PCI Readmissions Unveiled, Though Results Questioned by Some

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

Cardiome Announces Commercialization Partnership For BRINAVESS™ In Select European Markets

Thoratec Acquires DuraHeart® II Ventricular Assist System

The AHA Exclusively Endorses Simulation Based Training from Medical Simulation Corporation and Raytheon Professional Services

Updates from PARTNER 2A

Can We Afford TAVR? Impact on US Hospitals and Health Systems: Lessons from PARTNER and Beyond

Did STS Score or EuroScore Risk Profiles Predict Mortality Outcomes in PARTNER?

Vascular Complications: PARTNER Outcomes and Review of the Literature

Stroke Frequency and Timing after TAVR: Evolving Insights from the PARTNER Database

Retrospective Analysis of Poor Outcome Groups from the PARTNER Trial

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Meta-análisis: Aumenta la prevalencia de la enfermedad y el número de candidatos a TAVR

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

Registro: Mortalidad al Año Similar para la TAVR y la Cirugía en Pacientes de Riesgo Intermedio

Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content